Home » Newsletters » BioWorld Science

BioWorld Science

July 15, 2020

View Archived Issues

Brief anemia helps out nanoparticle drugs

CDK-like kinase plays role in sensing pain

Tonix Pharmaceuticals and K-State collaborate to develop vaccine against COVID19

Galectin-9 monoclonal antibody HFB9-2 displays favorable characteristics for further development

BPI-23314 shows promising activity in xenograft models of hematological malignancies

PC3X as a novel diagnostic and prognostic marker in HCC

Acurx Pharmaceuticals describes new bacterial DNA polymerase IIIC inhibitors

Apolipoprotein L1 inhibitors discovered at Vertex Pharmaceuticals

TOLREMO therapeutics patents compounds targeting CREBBP and p300 HAT

Celgene discovers androgen receptor degradation inducers

New activin receptor type-1 inhibitors identified at Incyte

Suzhou Kintor and Applied Biology to evaluate proxalutamide in COVID-19 study

First patient dosed in phase I study of NX-13

Phase III BOLD study of odevixibat in biliary atresia enrolls first patient

USP18 found to promote lung cancer growth

Down syndrome organoids give insights into Alzheimer's disease

First-in-human study of PD1-Vaxx gains HREC approval to begin in Australia

FDA approves Tremfya for active psoriatic arthritis

Fostamatinib begins clinical evaluation for COVID-19 pneumonia

Hackensack Meridian Health collaborates with Merck & Co. to discover COVID-19 treatments

SIGLEC15 is a prognostic marker in gastric cancer

NIAID grant to support development of Versamune-based universal influenza vaccine

NMD Pharma cleared to begin phase I/IIa trial of NMD-670 for myasthenia gravis

FDA issues CRL for Verrica's VP-102 to treat molluscum contagiosum

CDK7 inhibitor Q-901 induces potent tumor growth inhibition in vivo

Vadadustat begins study to prevent and treat ARDS in patients with COVID-19

FDA clears IND for phase I trial of CYAD-211 for multiple myeloma

Dosing begins in phase I trial of Medicago's COVID-19 vaccine with adjuvants

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 4, 2026.
ASCO 2026: A revolution in pancreatic cancer
BioWorld
At the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, Revolution Medicines Inc. followed up its stellar top-line data with the details from the...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 2, 2026
EASL 2026: Emerging liver disease targets to watch
BioWorld
At the recently concluded European Association for the Study of the Liver meeting, presentations underscored how increasingly granular insights into liver...
ASCO 2026: PD-(L)1 x VEGF bispecifics fight it out
BioWorld
Multiple companies are chasing Akeso Inc. and Summit Therapeutics Inc. in the battle to potentially dethrone Keytruda (pembrolizumab, Merck & Co. Inc.) as the top...